Quillivant XR Approval History 
- FDA approved: Yes (First approved September 27th, 2012)
- Brand name: Quillivant XR
- Generic name: methylphenidate
- Company: NextWave Pharmaceuticals, Inc.
- Treatment for: ADHD
Quillivant XR (methylphenidate) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
FDA Approval History for Quillivant XR
| Date | Article |
|---|---|
| Oct 1, 2012 |  NextWave Pharmaceuticals Receives FDA Approval of Quillivant XR for Once-Daily Treatment of ADHD |
See also...
Quillivant XR (methylphenidate) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
